Two long-lasting human monoclonal antibodies cross-react with monkeypox virus A35 antigen.
暂无分享,去创建一个
Bin Zhou | Zheng Zhang | Haiyan Wang | X. Liao | B. Ju | Xinrong Zhou | Lei Liu | Chengyan Zhao | L. Cheng | Xiangyang Ge | Xiaobo Lu
[1] X. Chuai,et al. Monkeypox virus: a re-emergent threat to humans , 2022, Virologica Sinica.
[2] D. Sobral,et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus , 2022, Nature Medicine.
[3] Y. Xiang,et al. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters , 2022, Emerging microbes & infections.
[4] F. Lienert,et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review , 2021, medRxiv.
[5] S. Ovchinnikov,et al. ColabFold: making protein folding accessible to all , 2022, Nature Methods.
[6] Linqi Zhang,et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection , 2020, Nature.
[7] Y. Nakazawa,et al. Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health , 2019, Expert review of anti-infective therapy.
[8] R. Eisenberg,et al. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections , 2016, Cell.
[9] Luis Villarreal,et al. Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.
[10] S. Hansen,et al. Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.
[11] E. A. Uvarova,et al. Analysis of the Monkeypox Virus Genome , 2002, Virology.
[12] P E Fine,et al. The transmission potential of monkeypox virus in human populations. , 1988, International journal of epidemiology.